Improving the Outcome of Bone Marrow Transplantation by Using CD52 Monoclonal Antibodies to Prevent Graft-Versus-Host Disease and Graft Rejection
Year: 1998
Type: article
Study design: Clinical Trial
Source: Blood
Institution: University of Oxford
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: U.S. Department of Health and Human Services, Samuel Roberts Noble Foundation, RGK Foundation, Amgen, Bristol-Myers Squibb, Pfizer, Kaiser Permanente, University of Nebraska Medical Center, George Washington University, University of Minnesota, Blue Cross and Blue Shield Association, University of Louisville, University of Oklahoma, Georgetown University, Intermountain Research and Medical Foundation, Louisiana State University, Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, Kay Kendall Leukaemia Fund, National Institutes of Health, Genentech, University of Oklahoma Health Sciences Center, Medical Research Council, National Cancer Institute, National Institute of Allergy and Infectious Diseases, Cliniques Universitaires Saint-Luc, U.S. Army Medical Research and Development Command
OpenAlex ID: W9635739